Chasteberry: History and Traditional Use

Chasteberry is the small, peppery fruit of Vitex agnus-castus, a Mediterranean shrub whose story runs in an unusually straight line from the ancient world to the modern clinic. Athenian women strewed its branches beneath them at the festival of Demeter; Dioscorides and Pliny gave its seed to bring on a period and to bring down milk; monks are said to have ground it as pepper to keep their vows; German physicians revived it in the 1930s and 1950s; and in the 1990s the laboratory found out what it does — nudge the pituitary through a dopamine-like effect and lower the hormone prolactin. Where the record is firm we say so; where a story is tradition, we call it tradition.

Table of Contents

  1. A Mediterranean Shrub and a Tangle of Names
  2. The Chaste Tree in Ancient Greece
  3. Dioscorides, Pliny and the Classical Physicians
  4. Monk's Pepper: The Medieval Tradition
  5. Gerard, Culpeper and the Renaissance Herbals
  6. Decline, and a German Revival (1930s–1950s)
  7. The Prolactin Story: Finding the Mechanism (1990s)
  8. Putting It to the Test: The Clinical Trials
  9. Monographs and Regulators: Commission E to the EMA
  10. Tradition and Evidence: Chasteberry Today
  11. Key Research Papers
  12. Connections
  13. Featured Videos

A Mediterranean Shrub and a Tangle of Names

Vitex agnus-castus is a deciduous shrub, sometimes a small tree, native to the Mediterranean basin and eastwards into Central Asia. It grows on damp ground — riverbanks, seasonal stream beds, the edges of marshes and beaches — and in late summer throws up slender spikes of lilac-blue flowers, followed by clusters of hard, dark, peppercorn-sized fruits with a warm, peppery smell. Those dried fruits are the "berry." Long filed in the verbena family, the genus Vitex now sits in the mint family (Lamiaceae); its Asian relative Vitex negundo, the nirgundi of Ayurveda, is a different plant.

The names are the first chapter of the history. The Greeks called it lygos and agnos. Lygos means a pliant withy, a twig you can bend and tie; it is the word Homer uses in the Odyssey for the "well-twisted withies" with which Odysseus lashes his men beneath the Cyclops' rams, and the standard Greek lexicon identifies it with this shrub. The same bendiness gave the Romans vitex, from vieo, "to weave"; Pliny introduces it as a plant "used in wicker-work."

Agnos is where the legend begins. It sounds almost exactly like hagnos, "pure, chaste," and the lexicon notes that the plant was "associated with the notion of chastity from the likeness of its name to hagnos." Dioscorides adds another folk etymology, agonon, "barren." Latin writers translated the pun rather than the word: agnus castus is Greek agnos plus Latin castus, "chaste," so the name says "chaste" twice. A later ear heard agnus, "lamb," and German still calls the plant Keuschlamm, "chaste lamb," beside Mönchspfeffer, "monk's pepper."

Back to Table of Contents

The Chaste Tree in Ancient Greece

Before it was a medicine the chaste tree was a sacred plant. Pausanias, touring Greece in the second century CE, records the Samian belief that Hera was born beside the river Imbrasus "under the withy (lygos) that even in my time grew in the Heraeum" — a living tree shown to visitors inside her great sanctuary on Samos. At Sparta, he says, Asclepius was worshipped as Agnitas "because the god had a wooden image of agnus castus." Plato's Phaedrus sets Socrates' riverside talk beneath a plane tree and a tall agnos in bloom; Theophrastus names it in his Enquiry into Plants.

The episode that fixed its reputation is the Thesmophoria, the autumn festival of Demeter kept by married women. Pliny the Elder (Natural History, 77 CE) says the Greeks call the shrub agnos "from the fact that the matrons of Athens, during the Thesmophoria, a period when the strictest chastity is observed, are in the habit of strewing their beds with the leaves of this tree." Dioscorides, a generation earlier, tells it in his own words: "it is called agnus because in the sacrifices to Ceres [Demeter] the chaste matrons used it for sprinkling under them." Two independent first-century authors agree, which makes the practice about as well attested as anything in ancient ritual. Its meaning is less certain — the ancients tie the branches to the festival's abstinence, some modern scholars to Demeter's fertility — but either way a plant that chaste women lay upon became, by an easy step, a plant that caused chastity (Pliny already lists "antaphrodisiac" among its powers). A pun and a bed of leaves are the whole foundation of the monk's-pepper legend.

Back to Table of Contents

Dioscorides, Pliny and the Classical Physicians

The chaste tree belongs to the official medicine of antiquity. The Hippocratic writings of the fifth and fourth centuries BCE list agnos among their drugs (the lexicon cites the treatise Internal Affections), and later herbal writers report Hippocratic uses for wounds, inflammation and the spleen; the specific "Hippocratic recipes" repeated online are hard to pin to a passage.

The first detailed account is Dioscorides' chapter on agnos in De Materia Medica (first century CE), a handbook that stayed in use for some fifteen hundred years. He describes the shrub accurately — tall, hard to break, "seed like that of pepper" — and lists its uses: "warming and astringent," good for snakebite, the spleen and dropsy, and — the sentence that matters most here — a spoonful "taken as a drink in wine brings down milk and expels the menstrual flow." He prescribes a decoction as a hip bath "for disorders and inflammation around the womb," a poultice for headache, and the leaves scattered to drive off venomous creatures; he notes that "it destroys generation" and that the Romans called it salix marina, sea willow, while others called it piper agreste, "wild pepper" — so the pepper idea is at least as old as Dioscorides and did not wait for the monasteries.

Pliny's chapter in Book 24 of the Natural History credits the vitex with thirty-three remedies: the seed is a reputed febrifuge (fever-reducer), a diuretic and an emmenagogue (a drug that brings on menstruation), relieves flatulence, is "remarkably useful for dropsy and affections of the spleen," and the fruits "promote the secretion of the milk." He adds antidotes against serpents and a pessary to cleanse the uterus. An indiscriminate list — but two threads run through Pliny and Dioscorides alike: the womb and the breast. Their humoral language is the framework of the system, not a mechanism; the target organs are the ones modern research would confirm.

Back to Table of Contents

Monk's Pepper: The Medieval Tradition

Every account tells the same story: medieval monks ground the peppery fruit as a condiment and took it, or strewed it in their dormitories, to dampen desire and keep their vows. The German Mönchspfeffer and the English "monk's pepper" preserve the tradition, and it has ancient roots — the antaphrodisiac claim is in Pliny, "wild pepper" in Dioscorides. What is hard to find is a medieval document that actually describes a monastery doing it. Modern herbals and regulatory assessments repeat the claim (the European Medicines Agency notes drily that the seeds "were believed to reduce libido"), but its evidence is mostly the names and later writers. Gerhard Madaus, in 1938, could still report that Italian monastery novices walked to their profession along paths strewn with its blossoms — an echo of the Thesmophoria, and as close to a primary source as the literature offers. The monk's-pepper tradition is real as a tradition, plausibly old, and thinly documented in its medieval details.

What is certain is that the plant never left the pharmacy. Dioscorides was copied and translated through the Middle Ages in Greek, Latin and Arabic, the chaste tree travelled with him into the printed herbals, and by the sixteenth century the seed was a stock apothecary item as agnus castus. Folk medicine kept its own uses alongside: Madaus records that in Hungary the fruit was a household remedy for abdominal complaints and irregular periods and was given to nursing mothers to increase milk — the same pairing of womb and breast that runs from Dioscorides onward. These are records of what people hoped for, not evidence of effect.

Back to Table of Contents

Gerard, Culpeper and the Renaissance Herbals

The English herbals carried the classical account almost unchanged. John Gerard's Herball (1597; enlarged by Thomas Johnson in 1633) gives "Vitex, or the Chaste tree" its own chapter — a bushy shrub of "hot regions, by water courses and running streams," and, Gerard adds, "I have it growing in my garden." On the name he reads carefully: "The Grecians call this shrub agnos, that is Castus, Chaste: because, saith Pliny in his 24. booke, the Athenian Matrons in their feast called Thesmophoria dedicated to the honour of Ceres… doe lay the leaves in their beds under them," His "Vertues" open with the sentence every later writer borrowed — "Agnus Castus is a singular medicine and remedy for such as would willingly live chaste" — and then treat it like any other carminative: the seed drunk "driveth away and dissolveth all windinesse of the stomacke."

Nicholas Culpeper gave it no chapter in his English Physician (1652), a book of native herbs, but his English translation of the London College of Physicians' Pharmacopoeia, bound into later editions of the Complete Herbal, shows how firmly agnus castus sat in official medicine: "Agnus Castus, &c. Chast-tree. The leaves are hot and dry in the third degree; expel wind, consume the seed, cause chastity being only borne about one; it dissolves swellings of the testicles, being applied to them, head-ache, and lethargy." The College also lists a compound Syrupus de Agno Casto, "Syrup of Agnus Castus," built on four ounces of the seed with lettuce, purslane and water-lily — a "cooling" syrup in the humoral sense. Note "being only borne about one": the chastity belief had become a charm carried on the person, while the gynaecological use stayed serious pharmacy.

Back to Table of Contents

Decline, and a German Revival (1930s–1950s)

Through the eighteenth and nineteenth centuries the chaste tree slipped out of the front rank of European medicine. As pharmacy turned to isolated alkaloids, a seed with a folkloric reputation and no identified active principle had little to recommend it, and it survived chiefly in Mediterranean and central-European folk use and in homoeopathy. There is no single moment when it "fell out of use"; the safe statement is that by 1900 most physicians in western Europe and North America had never prescribed it.

The revival came from Germany. Gerhard Madaus (1890–1942) was a physician who founded a plant-medicine firm with his brothers in 1920 and set out to document the whole European herbal tradition. His three-volume Lehrbuch der biologischen Heilmittel (Leipzig, 1938) gives Agnus castus, under the German name Keuschlamm, a full monograph: the classical history from Homer to Pausanias, the folk uses, and his own indications "for disturbances of the sexual functions" — deficient lactation after childbirth, absent or disturbed periods, female infertility, impotence, swellings of the spleen and glands — using a fresh-plant preparation of the autumn fruit. A traditional list, not an experimental one — but it fixed the modern indications.

From the 1950s German clinicians published case series with a proprietary tincture of the fruit. The European Medicines Agency's assessment lists them: Bautze (1953) and Mohr (1954) on milk production in postnatal wards; Probst and Roth (1954) on women whose absent periods returned; Bleier (1959) on menstrual disorders. None was a controlled trial, but they mark the plant's re-entry into clinical medicine. Chasteberry preparations have been on the German and Austrian markets continuously since at least 1968 — the "thirty years of documented use" European law would later require of a traditional herbal medicine.

Back to Table of Contents

The Prolactin Story: Finding the Mechanism (1990s)

For most of its history nobody could say why the chaste tree should touch a menstrual cycle, and it contains no single dramatic molecule to point the way. The answer was found not in the ovary but in the brain. The pituitary gland makes prolactin, the hormone that drives milk production, and the brain holds prolactin down with dopamine acting on D2 receptors on the prolactin-making cells — the natural "off switch." Mildly raised prolactin can disturb the second half of the cycle (the luteal phase) and swell the breasts before a period.

In 1993 Sliutz and colleagues in Vienna showed that extracts of agnus castus inhibited prolactin secretion by rat pituitary cells. In 1994 Jarry, Wuttke and co-workers in Göttingen supplied the crucial detail: in a dopamine-receptor binding assay, compounds in the extract bound the D2 receptor and inhibited prolactin release but not the other pituitary hormones LH and FSH — "direct evidence," their title said, "for a dopaminergic principle." Meier and colleagues (2000) traced the activity to the fat-soluble fraction and to labdane diterpenes such as rotundifuran, while the iridoids and flavonoids long used as marker compounds proved to have no dopaminergic activity; Wuttke's 2003 review identified a group of bicyclic clerodane diterpenes, the "clerodadienols," as the most potent constituents.

The discovery explains the ancient pairing of womb and breast — a plant that acts on prolactin will touch both — and it quietly reverses one strand of the tradition. Dioscorides, Pliny, Madaus and Hungarian folk medicine all gave the fruit to increase milk; a prolactin-lowering herb would be expected to do the opposite, and modern guidance advises against it during breastfeeding. Tradition asked the right questions and got one answer backwards — a traditional use is a hypothesis, not a result. The effect is gentle — a nudge to prolactin, not the suppression a prescription dopamine agonist produces.

Back to Table of Contents

Putting It to the Test: The Clinical Trials

The first controlled trial appeared in the same year as the first mechanism paper. Milewicz and colleagues (1993) randomised 52 women with luteal-phase defects attributed to "latent hyperprolactinaemia" — prolactin normal at rest but over-responsive to stimulation — to a chasteberry capsule or placebo for three months; the herb damped the prolactin response and lengthened the shortened luteal phase. It set the three-month duration every trial since has used. Halaska and colleagues (1999), in a placebo-controlled double-blind study of about a hundred women, found that a chasteberry solution taken for three cycles eased cyclical breast pain significantly more than placebo — a result a 2020 meta-analysis (Ooi and colleagues) has since supported.

The landmark was premenstrual syndrome. In January 2001 the BMJ published Schellenberg's randomised, placebo-controlled trial in 170 women with PMS, using a standardised dry extract (Ze 440) at 20 mg once daily for three cycles: 52% of women on the extract achieved at least a 50% reduction in symptoms against 24% on placebo, with side effects no more frequent than placebo. A multicentre placebo-controlled trial in China with a different extract (He and colleagues, 2009) agreed, and Schellenberg's dose-finding study (2012) compared 8, 20 and 30 mg daily and found 20 mg the effective dose — 8 mg did little better than placebo and 30 mg added nothing.

The systematic reviews then weighed it all. Van Die and colleagues (2013) judged the PMS evidence the most convincing of the herb's uses while flagging weak methods and industry funding; Verkaik and colleagues' meta-analysis (2017) found chasteberry consistently superior to placebo and warned just as consistently of bias and heterogeneity; and a systematic review of adverse events (Daniele and colleagues, 2005) found the side effects — nausea, headache, skin reactions, menstrual changes — mild and reversible. The honest verdict: genuinely better than placebo for ordinary premenstrual syndrome, moderate rather than dramatic, and resting on fewer and less perfect trials than the marketing suggests.

Back to Table of Contents

Monographs and Regulators: Commission E to the EMA

Germany's Commission E, the expert panel that evaluated herbal medicines for the federal health authority, published its monograph on Agni casti fructus in 1992, approving ethanolic extracts of the fruit at a daily dose corresponding to 30–40 mg of dried fruit for three indications: irregularities of the menstrual cycle, premenstrual complaints, and mastodynia (breast pain). It rested on the German clinical tradition, not on trials. The European Scientific Cooperative on Phytotherapy (ESCOP) followed with a monograph in 2003.

The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency adopted its first Community herbal monograph on Vitex agnus-castus L., fructus on 5 August 2011, under the "traditional use" heading — a category requiring thirty years of documented medicinal use rather than trials — for the "relief of minor symptoms in the days before menstruation (premenstrual syndrome)." The revision adopted on 10 October 2018 went further: on the strength of Schellenberg's 2001 and 2012 trials it granted well-established use status, the heading that requires published clinical evidence, to one specified preparation — a dry extract (drug-to-extract ratio 6–12:1, 60% ethanol) at 20 mg daily, taken continuously for three months, "for the treatment of premenstrual syndrome." Other preparations keep the traditional-use indication; a further periodic review opened in 2024.

Back to Table of Contents

Tradition and Evidence: Chasteberry Today

Chasteberry is now one of the most widely used herbal remedies for women's health in Europe and North America and unusual among such remedies in having a demonstrated mechanism and controlled trials behind its headline use. Unusually, it never yielded a single isolated molecule and came into modern medicine as a whole-fruit extract, tested as a whole and explained afterwards by a family of diterpenes acting on one receptor. That is why the good evidence applies to specific standardised extracts, not to "chasteberry" in the abstract, and why the European monograph names one preparation rather than the plant.

Tradition and science relate here in three different ways. On the menstrual cycle, tradition asked the right question and research confirmed a modest, real effect through prolactin. On the breast, tradition was half right: premenstrual breast pain is genuinely helped, but the ancient use to increase milk runs against the mechanism, and the modern advice is to avoid the herb while nursing. And on chastity — the claim that named the plant, decorated the Thesmophoria and seasoned the monks' food — there is no modern evidence at all; it was a pun that became a legend. The plant's most famous property is its least real one. For what the herb does today, how it is dosed and where it interacts with other medicines, see the Chasteberry hub and its Benefits pages.

Back to Table of Contents

Key Research Papers

The modern landmarks: the first mechanism papers on prolactin and the dopamine D2 receptor, the active diterpenes, the first controlled trials and the systematic reviews that weigh them. The ancient and Renaissance texts are named in the article and not cited here.

  1. Sliutz G, Speiser P, Schultz AM, Spona J, Zeillinger R (1993). Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Hormone and Metabolic Research. — PubMed PMID: 8330858
  2. Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, Schmitz H (1993). Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittel-Forschung. — PubMed PMID: 8369008
  3. Jarry H, Leonhardt S, Gorkow C, Wuttke W (1994). In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Experimental and Clinical Endocrinology. — PubMed PMID: 7890021
  4. Halaska M, Beles P, Gorkow C, Sieder C (1999). Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. The Breast. — PubMed PMID: 14731436
  5. Meier B, Berger D, Hoberg E, Sticher O, Schaffner W (2000). Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine. — PubMed PMID: 11081988
  6. Schellenberg R (2001). Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. — doi:10.1136/bmj.322.7279.134
  7. Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlová-Wuttke D (2003). Chaste tree (Vitex agnus-castus) — pharmacology and clinical indications. Phytomedicine. — PubMed PMID: 12809367
  8. Schellenberg R, Zimmermann C, Drewe J, Hoexter G, Zahner C (2012). Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome. Phytomedicine. — PubMed PMID: 23022391
  9. van Die MD, Burger HG, Teede HJ, Bone KM (2013). Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Medica. — PubMed PMID: 23136064
  10. Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ (2017). The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. — PubMed PMID: 28237870

PubMed Topic Searches

  1. PubMed: Chasteberry ethnobotany and traditional use
  2. PubMed: Chasteberry, prolactin and dopamine — the pharmacology
  3. PubMed: Chasteberry randomised trials in premenstrual syndrome

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents